Primary Care Enhanced Services
Overview
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board has awarded a contract under the Provider Selection Regime regulations for the provision of Primary Care Enhanced Services. The contract, specifically dedicated to general-practitioner services, includes a range of services like Phlebotomy, Treatment Room, Leg Ulcer care, and specialised drug monitoring. The contract was confirmed on 7th November 2025 and will be executed from 1st April 2025 to 31st March 2026 in the UKF3 region.
This procurement process used a direct award method with the limited procurement procedure, bypassing the need for prior competition due to its specific legal framework, valued at £35,308. This contracting opportunity is significant for businesses within the healthcare industry, especially those already involved in general-practitioner services, as it highlights trust in continuity and quality of service delivery by The Sutterton Surgery, a small to medium-sized enterprise. Organisations adept in phlebotomy, specialised drug monitoring, and related healthcare services could find future opportunities for collaboration or sub-contracting under similar frameworks.
The lack of a competitive bid process suggests that well-established providers in the region might benefit significantly, positioning them for subsequent direct awards or ensuring their longevity in the healthcare supply chain.
NHS Lincolnshire ICB has utilised direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding
NHS Lincolnshire ICB has utilised direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS35308 The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Tobacco Dependency Service in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Provision of Intermediate Minor Oral Surgery and Conscious Sedation at Oasis - Lincoln in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- GP Practice Medical Cover for Hospice in the Hospital in North Kesteven